Related Experiment Video
Updated: Dec 17, 2025

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
What ketamine can teach us about the opioid system in depression?
Laura Perez-Caballero1,2, Victor Perez2,3,4, Esther Berrocoso1,2
1Neuropsychopharmacology & Psychobiology Research Group, Area of Psychobiology, Department of Psychology, University of Cádiz , Cádiz, Spain.
No abstract available in PubMed .
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
06:15A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
Published on: July 15, 2025
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Antidepressant Drugs: MAOIs and Other Agents
Parenteral Anesthetics: Overview
Depressants
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Analgesia and Pain Management